# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057017
Filing Date
2024-05-09
Accepted
2024-05-09 16:20:33
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ivvd-20240331.htm iXBRL | 10-Q | 1331336
2 | EX-31.1 | ivvd-ex31_1.htm | EX-31.1 | 17124
3 | EX-31.2 | ivvd-ex31_2.htm | EX-31.2 | 17033
4 | EX-32.1 | ivvd-ex32_1.htm | EX-32.1 | 10517
5 | EX-32.2 | ivvd-ex32_2.htm | EX-32.2 | 9986
| Complete submission text file | 0000950170-24-057017.txt |  | 6217875

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ivvd-20240331.xsd | EX-101.SCH | 1146278
68 | EXTRACTED XBRL INSTANCE DOCUMENT | ivvd-20240331_htm.xml | XML | 891496

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 24931034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)